MK2 inhibitors

The present invention relates to compounds of general Formula (I) or a pharmaceutically acceptable salt thereof. The compounds can be used in the treatment of immune, autoimmune, inflammatory diseases, cardiovascular diseases, infectious diseases, bone resorption disorders, neurodegenerative disease...

Full description

Saved in:
Bibliographic Details
Main Authors OUBRIE ARTHUR, BARF TJEERD ANDRIES, ZWART EDUARD WILLEM, DE WILDE SANDER MARTIJN, HOOGENBOOM NIELS, KAPTEIN ALLARD, SCHULTZ-FADEMRECHT CARSTEN
Format Patent
LanguageEnglish
Published 08.07.2014
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to compounds of general Formula (I) or a pharmaceutically acceptable salt thereof. The compounds can be used in the treatment of immune, autoimmune, inflammatory diseases, cardiovascular diseases, infectious diseases, bone resorption disorders, neurodegenerative diseases or proliferative diseases.
Bibliography:Application Number: US201013514865